Gene · 4118
Papers2,902
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,902
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis. | EMBO J | 2024 | 39294473 | PubTator, text mining | PubMed |
| Microcrystal electron diffraction structure of Toll-like receptor 2 TIR-domain-nucleated MyD88 TIR-domain higher-order assembly. | Acta Crystallogr D Struct Biol | 2024 | 39268708 | PubTator, text mining | PubMed |
| Serum Circulating mRNA Panel for the Early Detection of Gastric Cancer: A Potential Biomarker Test. | ChemMedChem | 2024 | 39234977 | PubTator, text mining | PubMed |
| Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype. | Blood | 2024 | 39158068 | PubTator, text mining | PubMed |
| Co-transcriptional production of programmable RNA condensates and synthetic organelles. | Nat Nanotechnol | 2024 | 39080489 | PubTator, text mining | PubMed |
| Comparative functional morphology indicates niche partitioning among sympatric marine reptiles. | R Soc Open Sci | 2024 | 39076819 | PubTator, text mining | PubMed |
| Regulation of Precise DNA Repair by Nuclear Actin Polymerization: A Chance for Improving Gene Therapy? | Cells | 2024 | 38994946 | PubTator, text mining | PubMed |
| The contribution of silencer variants to human diseases. | Genome Biol | 2024 | 38978133 | PubTator, text mining | PubMed |
Performance of CADM1, MAL and miR124-2 methylation as triage markers for early detection of cervical cancer in self-collected and clinician-collected samples: an exploratory observational study in Papua New Guinea. | BMJ Open | 2024 | 38904134 | PubTator, text mining | PubMed |
| The contribution of silencer variants to human diseases. | medRxiv | 2024 | 38798661 | PubTator, text mining | PubMed |
| Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface. | J Transl Med | 2024 | 38760813 | PubTator, text mining | PubMed |
| Molecular analysis for ovarian cancer detection in patient-friendly samples. | Commun Med (Lond) | 2024 | 38755429 | PubTator, text mining | PubMed |
| Detecting normal and cancer skin cells via glycosylation and adhesion signatures: A path to enhanced microfluidic phenotyping. | Biosens Bioelectron | 2024 | 38703495 | PubTator, text mining | PubMed |
| MAL, a potential immunotherapy target, is associated with poor prognosis in cancer patients. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38678596 | PubTator, text mining | PubMed |
| Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways. | Viruses | 2024 | 38675975 | PubTator, text mining | PubMed |
MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2. | Clin Epigenetics | 2024 | 38461243 | PubTator, text mining | PubMed |
| o-Vanillin binds covalently to MAL/TIRAP Lys-210 but independently inhibits TLR2. | J Enzyme Inhib Med Chem | 2024 | 38416868 | PubTator, text mining | PubMed |
| A chemo/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy. | Carbohydr Polym | 2024 | 38286559 | PubTator, text mining | PubMed |
| Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets. | Cell Commun Signal | 2024 | 38279122 | PubTator, text mining | PubMed |
| Grade-4/5 motor activity log-Brazil for post-stroke individuals with a severely impaired upper limb: a validity, reliability and measurement error study. | Disabil Rehabil | 2024 | 38265026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4118/papers?page=5